Evidence map›Paper›PMID 27654582›Full record

ArticleInvestigative radiology2016

Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?

Shiying Wang, Elizabeth B Herbst, F William Mauldin, Galina B Diakova, Alexander L Klibanov, John A Hossack

Open access · greenAbstract read
In one paragraph

Article in Investigative radiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Molecular Ultrasound Imaging.Nanomaterials (Basel, Switzerland) · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shiying WangFrom the *Department of Biomedical Engineering, †Division of Cardiovascular Medicine, Cardiovascular Research Center, and ‡Department of Electrical and Computer Engineering, University of Virginia, Charlottesville, VA.
Elizabeth B Herbst
F William Mauldin
Galina B Diakova
Alexander L Klibanov
John A Hossack
University of Virginia · US

Funding

QUANTITATIVE 3D ULTRASOUND IMAGING OF THE MURINE HEARTR01EB001826 · NIBIB · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HOSSACK, JOHN A · 2003 to 2012
$2.4M
Ultrasound Targeted Molecular Imaging in Large Arteries to Diagnose Stroke RiskR01HL111077 · NHLBI · UNIVERSITY OF VIRGINIA · PI HOSSACK, JOHN A · 2012 to 2015
$1.4M
ULTRASOUND BIOMICROSCOPY OF SMALL ANIMAL ANATOMY AND PHYSIOLOGY WITH THE vevo 770S10RR022582 · NCRR · UNIVERSITY OF VIRGINIA · PI HOSSACK, JOHN A · 2006 to 2006
$234k
NCRR NIH HHS S10 RR022582NHLBI NIH HHS R01 HL111077NIBIB NIH HHS R01 EB001826
6 · The paper itself

Abstract

objectivesThe objective of this study was to evaluate the minimum microbubble dose for ultrasound molecular imaging to achieve statistically significant detection of angiogenesis in a mouse model. MATERIALS AND

methodsThe preburst minus postburst method was implemented on a Verasonics ultrasound research scanner using a multiframe compounding pulse inversion imaging sequence. Biotinylated lipid (distearoyl phosphatidylcholine-based) microbubbles that were conjugated with antivascular endothelial growth factor 2 (VEGFR2) antibody (MBVEGFR2) or isotype control antibody (MBControl) were injected into mice carrying adenocarcinoma xenografts. Different injection doses ranging from 5 × 10 to 1 × 10 microbubbles per mouse were evaluated to determine the minimum diagnostically effective dose.

resultsThe proposed imaging sequence was able to achieve statistically significant detection (P < 0.05, n = 5) of VEGFR2 in tumors with a minimum MBVEGFR2 injection dose of only 5 × 10 microbubbles per mouse (distearoyl phosphatidylcholine at 0.053 ng/g mouse body mass). Nonspecific adhesion of MBControl at the same injection dose was negligible. In addition, the targeted contrast ultrasound signal of MBVEGFR2 decreased with lower microbubble doses, whereas nonspecific adhesion of MBControl increased with higher microbubble doses.

conclusionsThe dose of 5 × 10 microbubbles per animal is now the lowest injection dose on record for ultrasound molecular imaging to achieve statistically significant detection of molecular targets in vivo. Findings in this study provide us with further guidance for future developments of clinically translatable ultrasound molecular imaging applications using a lower dose of microbubbles.

Indexed as

AdenocarcinomaAnimalsContrast MediaDisease Models, AnimalFemaleMiceMice, Inbred C57BLMicrobubblesMolecular ImagingNeovascularization, PathologicPhosphatidylcholinesUltrasonographyVascular Endothelial Growth Factor Receptor-21,2-distearoyllecithinContrast MediaPhosphatidylcholinesVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID27654582
PMCPMC5099110
OpenAlexW2523164470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.